-
1
المؤلفون: C Iniesta Navalón, C Pastor Mondéjar, Mdc Caballero Requejo, M García Coronel, I Salar Valverde, AM Martínez Soto, E Urbieta Sanz, M Gil Candel, P Ortíz Fernández, A Quesada Asencio, M Onteniente Candela
المصدر: Section 5: Patient safety and quality assurance.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Abatacept, medicine.disease, Golimumab, Infliximab, Etanercept, Discontinuation, chemistry.chemical_compound, Tocilizumab, chemistry, Internal medicine, Rheumatoid arthritis, Adalimumab, medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5ebf5883cde6f83ba5de670ae212e3ccTest
https://doi.org/10.1136/ejhpharm-2021-eahpconf.298Test -
2
المؤلفون: C Iniesta Navalón, AM Martínez Soto, L Rentero Redondo, I Salar Valverde, Mdc Caballero Requejo, M Onteniente Candela, M Gil Candel, P Ortíz Fernández, A Quesada Asencio, E Urbieta Sanz, C Pastor Mondéjar
المصدر: Section 5: Patient safety and quality assurance.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Ankylosing spondylitis, business.industry, Retrospective cohort study, Neutropenia, medicine.disease, Etanercept, Discontinuation, Psoriatic arthritis, Internal medicine, Rheumatoid arthritis, medicine, business, Adverse effect, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2c7534f21ab30b87349d4a9a527739cdTest
https://doi.org/10.1136/ejhpharm-2021-eahpconf.295Test -
3
المؤلفون: MA Velaz Suarez, BC Sánchez Lerma, AL García Silva, MP González Joyanes, Y Hernández Gago, Má Perez Cruz
المصدر: Section 4: Clinical Pharmacy Services.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Abdominal pain, Anakinra, business.industry, Amyloidosis, Cochrane Library, Gene mutation, medicine.disease, Etanercept, Sepsis, Prednisone, Internal medicine, Medicine, medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::261d26348dbcc40769a65200b4e94e06Test
https://doi.org/10.1136/ejhpharm-2020-eahpconf.231Test -
4
المؤلفون: S Barbadillo Villanueva, S Lorenzo Martin, F Uriarte Estefanía, MV Villacañas Palomares, A Colón López de Dicastillo, E Parra Alonso
المصدر: Section 5: Patient Safety and Quality assurance.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Golimumab, Etanercept, Sarilumab, chemistry.chemical_compound, Tocilizumab, chemistry, Internal medicine, Ustekinumab, medicine, Adalimumab, Dosing, business, Adverse effect, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5f239127ea6f7f04738bc46fb5f32091Test
https://doi.org/10.1136/ejhpharm-2020-eahpconf.419Test -
5
المؤلفون: EP Gómez-Caballero, B Bertran De Lis-Bartolome, C Moriel-Sanchez, M Mañes Sevilla, I Soto Baselga
المصدر: Section 4: Clinical Pharmacy Services.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Abatacept, medicine.disease, Golimumab, Infliximab, Etanercept, Psoriatic arthritis, Internal medicine, Ustekinumab, medicine, Adalimumab, Secukinumab, skin and connective tissue diseases, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::587de27baa19a0c43757713660eb5c6fTest
https://doi.org/10.1136/ejhpharm-2020-eahpconf.208Test -
6
المؤلفون: T Salvador Gómez, R Fresquet Molina, O Horna Oreja, MA Alcácera López, M Gimeno Gracia, JM Vinuesa Hernando, A Frutos Perez-Surio, R Gracia Piquer, FJ Campos Montellano, M Galindo Allueva
المصدر: Section 4: Clinical Pharmacy Services.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Spondyloarthropathy, Biosimilar, medicine.disease, Inflammatory bowel disease, Etanercept, Psoriatic arthritis, Rheumatoid arthritis, Psoriasis, Internal medicine, medicine, Adalimumab, skin and connective tissue diseases, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::13a5604968f3cdb2b89a6ca678b4f7d9Test
https://doi.org/10.1136/ejhpharm-2020-eahpconf.259Test -
7
المصدر: Section 5: Patient Safety and Quality Assurance.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Cost effectiveness, Retrospective cohort study, Biosimilar, medicine.disease, Rheumatology, Etanercept, Rheumatoid arthritis, Concomitant, Internal medicine, Cohort, Medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ebd2e43996fb243f28c423fd08712a02Test
https://doi.org/10.1136/ejhpharm-2019-eahpconf.510Test -
8
المؤلفون: I Plasencia García, M Suarez Gonzalez, E Gómez Melini, E Ramos Santana, S Hernández Rojas, MA Ocaña Gomez, P Diaz Ruiz, J Merino Alonso
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: musculoskeletal diseases, Moderate to severe, medicine.medical_specialty, Cost comparison, business.industry, medicine.disease, Dermatology, Etanercept, Psoriasis, Ustekinumab, Adalimumab, medicine, Secukinumab, Interleukin 17, skin and connective tissue diseases, business, Section 4: Clinical pharmacy services, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb82c7cbb1785b38956381db4a8a3fbTest
https://doi.org/10.1136/ejhpharm-2018-eahpconf.131Test -
9
المؤلفون: F. Guimerá Martín-Neda, J Rodríguez Ramos, B Del Rosario Garcia, M. Garcia Bustinduy, S García Gil, GJ Nazco Casariego, F Gutiérrez Nicolás, J González García
المصدر: Eur J Hosp Pharm
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, Significant difference, medicine.disease, humanities, Etanercept, Clinical trial, Internal medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, Observational study, In patient, business, Section 4: Clinical pharmacy services, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab8a588fecbd883e3d5a8a6a9d79c5fTest
https://doi.org/10.1136/ejhpharm-2018-eahpconf.237Test -
10CP-171 Biological drugs: persistence rate in patients with rheumatoid arthritis and spondylarthritis
المؤلفون: M Santoro, G Cannarile, A Semeraro, F Digiuseppe, G Mingolla, L D’Aprile, G Giglio, M Castellana
المصدر: Clinical pharmacy.
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, business.industry, medicine.disease, Golimumab, Infliximab, Rheumatology, Etanercept, chemistry.chemical_compound, Psoriatic arthritis, Tocilizumab, chemistry, Internal medicine, Ustekinumab, Physical therapy, Adalimumab, Medicine, skin and connective tissue diseases, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::48faf12fe8c2e76bd610cf9357675367Test
https://doi.org/10.1136/ejhpharm-2017-000640.169Test